BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11098803)

  • 1. CAMCOG as a screening instrument for dementia: the Odense study. Cambridge Cognitive Examination.
    Lolk A; Nielsen H; Andersen K; Andersen J; Kragh-Sørensen P
    Acta Psychiatr Scand; 2000 Nov; 102(5):331-5. PubMed ID: 11098803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
    Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting risk of 2-year incident dementia using the CAMCOG total and subscale scores.
    Restaino M; Matthews FE; Minett T; Albanese E; Brayne C; Stephan BC
    Age Ageing; 2013 Sep; 42(5):649-53. PubMed ID: 23872637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cambridge Cognitive Examination (CAMCOG): validation of the Hebrew version in elderly demented patients.
    Heinik J; Werner P; Mendel A; Raikher B; Bleich A
    Int J Geriatr Psychiatry; 1999 Dec; 14(12):1006-13. PubMed ID: 10607967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the Cambridge Cognitive Examination - revised a good tool for detection of dementia in illiterate Brazilian older adults?
    Paradela EM; Lourenço RA
    Geriatr Gerontol Int; 2014 Oct; 14(4):763-8. PubMed ID: 24666650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAMDEX, can it be more efficient? Observational study on the contribution of four screening measures to the diagnosis of dementia by a memory clinic team.
    van Hout H; Teunisse S; Derix M; Poels P; Kuin Y; Vernooij-Dassen M; Grol R; Hoefnagels W
    Int J Geriatr Psychiatry; 2001 Jan; 16(1):64-9. PubMed ID: 11180487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis of dementia in the elderly. A comparison of CAMCOG (the cognitive section of CAMDEX), the AGECAT program, DSM-III, the Mini-Mental State Examination and some short rating scales.
    Blessed G; Black SE; Butler T; Kay DW
    Br J Psychiatry; 1991 Aug; 159():193-8. PubMed ID: 1773235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAMCOG--a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample.
    Huppert FA; Brayne C; Gill C; Paykel ES; Beardsall L
    Br J Clin Psychol; 1995 Nov; 34(4):529-41. PubMed ID: 8563660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of very mild to severe dementia and Alzheimer's disease in Denmark: the Odense Study.
    Andersen K; Nielsen H; Lolk A; Andersen J; Becker I; Kragh-Sørensen P
    Neurology; 1999 Jan; 52(1):85-90. PubMed ID: 9921853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Cambridge Cognitive Examination as a tool for detection of dementia].
    Lozano-Gallego M; Vilalta-Franch J; Llinàs-Reglà J; López-Pousa S
    Rev Neurol; 1999 Feb 16-28; 28(4):348-52. PubMed ID: 10714310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of very mild to severe dementia in Denmark.
    Andersen K; Lolk A; Nielsen H; Andersen J; Olsen C; Kragh-Sørensen P
    Acta Neurol Scand; 1997 Aug; 96(2):82-7. PubMed ID: 9272182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence and incidence of dementia in Denmark. The Odense study].
    Andersen K; Lolk A; Nielsen H; Kragh-Sørensen P
    Ugeskr Laeger; 2000 Aug; 162(33):4386-90. PubMed ID: 10962962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CAMCOG: a useful screening instrument for dementia in stroke patients.
    de Koning I; van Kooten F; Dippel DW; van Harskamp F; Grobbee DE; Kluft C; Koudstaal PJ
    Stroke; 1998 Oct; 29(10):2080-6. PubMed ID: 9756586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of the Brazilian version of the informant questionnaire on cognitive decline in the elderly at screening for dementia in community-dwelling elderly participants: findings from FIBRA-RJ study.
    Lourenço RA; Sanchez MA
    J Geriatr Psychiatry Neurol; 2014 Sep; 27(3):212-9. PubMed ID: 24614204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test.
    Hobson P; Meara J
    Age Ageing; 1999 Jan; 28(1):39-43. PubMed ID: 10203203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of agreement between general practitioner detection of dementia and the revised Cambridge Cognitive Assessment (CAMCOG-R).
    Pond CD; Mate KE; Phillips J; Stocks NP; Magin PJ; Weaver N; Brodaty H
    Int Psychogeriatr; 2013 Oct; 25(10):1639-47. PubMed ID: 23800652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of the Rotterdam-CAMCOG in post-stroke dementia.
    de Koning I; van Kooten F; Koudstaal PJ; Dippel DW
    J Neurol Neurosurg Psychiatry; 2005 Feb; 76(2):263-5. PubMed ID: 15654047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A short screening instrument for poststroke dementia : the R-CAMCOG.
    de Koning I; Dippel DW; van Kooten F; Koudstaal PJ
    Stroke; 2000 Jul; 31(7):1502-8. PubMed ID: 10884444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the CAMCOG be a good cognitive test for patients with Alzheimer's disease with low levels of education?
    Aprahamian I; Martinelli JE; Cecato J; Izbicki R; Yassuda MS
    Int Psychogeriatr; 2011 Feb; 23(1):96-101. PubMed ID: 20678300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some psychometric properties of the CAMCOG.
    Lindeboom J; Ter Horst R; Hooyer C; Dinkgreve M; Jonker C
    Psychol Med; 1993 Feb; 23(1):213-9. PubMed ID: 8475210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.